Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

3SCTS
3SCTS
Home
Times are shown in your local time zone (GMT )
User Headshot

Dr Sze Hang Calvin Ng

Professional Bio

Dr Ng is Professor in Thoracic Surgery at Prince of Wales Hospital, The Chinese University of Hong Kong, and Honorary Consultant Surgeon at New Territory East Cluster (NTEC) hospitals. He is a pioneer in Single Port (Uniportal) VATS in the Asia-Pacific region, performing the first single port VATS lobectomy in Hong Kong in 2012. His interest in hybrid operating room (HOR) image-guided surgery led to world's first publications of HOR use in single port VATS major lung resection in 2015, and image-guided electromagnetic navigation bronchoscopy (iENB) in 2016. In March 2019, he led his world renowned HOR-iENB team to perform Asia-Pacific's first HOR non-invasive bronchoscopic microwave ablation for treatment of lung cancer. He is a Co-PI of NAVABLATE, the international study on bronchoscopic microwave ablation for treatment of lung cancer, and has accumulated the world's largest experience of this technique. He is also Co-PI of TARGET trial and PI of FLEX-MC MET, investigating utilization of robotic assisted bronchoscopy in diagnosis and therapy.
 
 His academic contributions include 24 book chapters (including in Pearson's Thoracic & Esophageal Surgery 3rd & 4th Eds, Shield's Thoracic Surgery 8th Eds), and more than 230 publications in indexed international journals (Citations 3347; H-index 30; ResearcherID; May-2021). Dr Ng is the corresponding Editor of the book Atlas of Uniportal Video Assisted Thoracic Surgery (Springer Science), the standard text for uniportal VATS surgeons, and Associate Editor of the book Lung Cancer (1st & 2nd Editions).
 
 Dr Ng supervises a team of postgraduate students to study molecular biology of lung cancer and therapeutic role of ablation for lung diseases. He closely collaborates with Departments of Clinical Oncology (led by Prof Tony Mok), Anatomical Cellular Pathology and Biomechanical Engineering, through several competitive grants to study targeted therapies in lung cancer, magnetic actuated surgical endoscopes, organoids and nanoparticles in cancer therapy.